Neuroendoscopy Market

Global Neuroendoscopy Market Size (2024 to 2029)

The global neuroendoscopy market is anticipated to grow to USD 306.18 million by 2029 from USD 236.50 million in 2024, with a registering CAGR of 5.3% during the forecast period. 

To traverse and access the tumor, neurosurgeons perform a procedure known as neuroendoscopy, which uses an endoscope as the primary tool. In contrast, open brain surgery requires more time for recovery after surgery and causes less pain; in this procedure, the tumor is removed, or a sample of it is taken (a biopsy). Then neurosurgeons attach special instruments to the endoscope, frequently an additional endoscope with forceps and scissors. Compared to conventional brain surgery, this procedure leaves fewer scars, does less harm to common structures, and has a lower risk of consequences. For example, a study found that 12.67% of problems from minimally invasive neurosurgery were preventable. Skull base, acoustic neuromas, hydrocephalus, colloid and arachnoid cysts, and pituitary tumors are a few conditions treated with neuroendoscopy.

Global Neuroendoscopy Market DRIVERS:

The rising need for minimally invasive surgical treatments, an aging population, and favorable reimbursement policies are majorly propelling the growth of the neuroendoscopy market.Additionally, the advantages of neuroendoscopic surgery over traditional brain surgery, the increased prevalence of neurological illnesses, and supportive government initiatives contribute to the market's overall growth. On the other hand, the advantages of neuroendoscopic surgery over traditional brain surgery, the increased prevalence of neurological illnesses, and supportive government initiatives contribute to the market's overall growth.

Increasing rates of neurological disorders to promote neuroendoscopy market growth.Treatment for various neurological conditions, including pineal area tumors, pituitary tumors, Rathke's cleft cysts, skull base tumors, and ventricular tumors, is increasingly done using neuroendoscopy methods. As a result, its application is expanding in neuro-oncology, brain biopsies, and hydrocephalus therapy, pushing the market's expansion.

According to GLOBOCAN 2012, brain and, nervous system cancer incidence rates were projected to rise by 6.6 percent globally from 2012 to 2015. Similarly, according to the Global Burden of Disease Study 2015, neurological disorders were ranked as the second-leading cause group for deaths (9.4 million or 16.8 percent of global deaths) and the leading cause group for disability-adjusted life-years (DALYs) in 2015 (approximately 250.7 million DALYs or 10.2 percent of global DALYs).

Global Neuroendoscopy Market RESTRAINTS:

The high cost of equipment and treatment could become a hurdle to the growth of the neuroendoscopy market.A neuroendoscopy device can cost up to $15,000 on the list price, on average. Particularly in developing nations like India, Brazil, and Mexico, healthcare providers lack the financial money to invest in such expensive, complex technologies. Additionally, medical personnel must receive training in the proper use and upkeep of neuroendoscopy devices and apparatus; this is a severe problem due to the high expense of neuroendoscopic procedure training. Only a small percentage of surgeons choose to pursue neuroendoscopy training due to the expensive cost of the program. Neuroendoscopy operations are typically expensive because of the high cost of the equipment as well as the increased activity and maintenance expenditures. This is a significant element impeding the market for neuroendoscopy devices from expanding.

Impact Of Covid-19 On The Global Neuroendoscopy Market:

The need for medical supplies is growing due to the afflicted population. The most common medical devices used in first-line clinical care are respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors. Additionally, COVID-19 has caused a significant increase in demand for medical goods such as masks, gloves, and protective eyewear. The need for medical supplies continues to grow among the public and healthcare professionals due to the increase in COVID-19 cases worldwide. To maintain a good and ongoing collection of PPE in the market, manufacturers of these items can benefit from the rising demand for medical supplies. Thus, the covid-19 pandemic seems to affect the neuroendoscopy market significantly.

REPORT COVERAGE:

This research report on the global neuroendoscopy market has been segmented based on product, application, usability, patients age, end-user, and region.

Global Neuroendoscopy Market - By Product:

• Flexible Endoscopes
• Rigid Endoscopes

Based on the product, the rigid endoscopes segment held approximately 70% of the share in the global neuroendoscopy market in 2021. The market has grown due to increasingly rigorous endoscope applications in intraventricular neuroendoscopy and the emergence of novel products in the neuroendoscopy sector.

Global Neuroendoscopy Market - By Application:

• Intraventricular Neuroendoscopy
• Transcranial Neuroendoscopy
• Transnasal Neuroendoscopy

Based on the application, the transcranial neuroendoscopy segment is anticipated to have the quickest growth rate in the global neuroendoscopy market, with a CAGR of 5.2%. Transcranial endoscopic preoperative imaging advancements have enabled neurosurgeons to plan and handle complex situations using less invasive techniques.

Global Neuroendoscopy Market - By Usability:

• Disposable Endoscopes
• Reusable Endoscopes

Based on usability, the disposable endoscopes segment held the largest share of the global neuroendoscopy market in 2022. Disposable neuroendoscopes are less expensive than reusable neuroendoscopes. Due to their single-use design, they also reduce the risk of infection. Because they are less expensive, disposable neuroendoscopes can be employed in developing nations.

Global Neuroendoscopy Market - By Patient's Age:

• Pediatric Patient
• Adult Patient

Based on the patient's age, the pediatric segment is anticipated to expand the fastest, with a CAGR of 6.89% during the forecast period. The demand for this market segment will be driven by the rise in pediatric tumor cases and the number of skilled pediatric neurosurgeons. In the U.S., there are 5.14 instances of brain cancer for every 100,000 children under the age of 15, according to a study published in the NCBI.

Global Neuroendoscopy Market - By End-Use:

• Diagnostic Centers
• Ambulatory Surgical Centers
• Hospitals
• Others

Based on the end-user, the hospital segment dominated the global neuroendoscopy market in 2022. Modern infrastructure, patient insurance, qualified medical staff, and an increase in neurosurgeries will contribute to the market's growth. According to an NCBI study, there are now about 50,000 neurosurgeons practicing worldwide. As a result, more neurosurgeons are anticipated to meet the growing demand for neurosurgery, which will accelerate market expansion in this sector.

Global Neuroendoscopy Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, the North American region led the global neuroendoscopy market in 2022 and is expected to continue growing during the forecast period. One of the critical drivers of regional growth is the existence of large corporations in North America. In addition, the market size in North America will also increase due to the rising occurrence of acute pediatric brain tumors. Another supporting growth is the population's growing need for minimally invasive procedures. The increasing demand for better healthcare in regions like the U.S. and Canada will grow the regions.

The neuroendoscopy devices market is predicted to experience exponential growth in Asia Pacific because brain tumors are becoming more common, and the frequency of hospital biopsies will suggest regional development. Rising healthcare costs in developing nations like Vietnam, India, and other countries will also help grow the Asia Pacific neuroendoscopy market. The increase in the elderly population Consequently, the senior population is growing in several countries, including India, China, Japan, etc., leading to the region's growth.

The market for neuroendoscopy in Europe is predicted to grow due to the continent's rising incidence of pituitary tumors. Additionally, skilled neurosurgeons in nations like the UK, Germany, France, and others will foster market expansion. 

The MEA region accounted for a small share of the global market in 2022, and this limited segment share in the Middle East and Africa is due to the population's lack of knowledge about various minimally invasive neurosurgery treatments. 

KEY MARKET PLAYERS:

A few of the prominent players operating in the global neuroendoscopy market profiled in this report are KARL STORZ, B.Braun, Ackermann Instrumente, Adeor Medical, Hangzhou Hawk, Claus Medical, Schindler Endoskopie, Tonglu Wanhe Medical Instrument, Machida Endoscope, Messe Dusseldorf GmbH, Medtronic, Melsungen AG, Olympus Corporation, Stryker, Boston Scientific Corporation, FUJIFILM Holding Corporation, HOYA Corporation, Cook, etc. 

RECENT MARKET DEVELOPMENTS:

• Drs. Dhandapani SS, Sushant, and Rijuneeta, endoscopic skull base surgeons from the Department of Neurosurgery and the Department of ENT at PGIMER, have performed the youngest patient operation in history to remove a massive brain tumor (craniopharyngioma) through the nose.
• Smartphones can help neurosurgeons with complex procedures. Mauricio Mandel, MD, and colleagues from So Paulo, Brazil, describe a smartphone-endoscope system for use in minimally invasive neurosurgery in a work that was just published in the Journal of Neurosurgery under the title "Smartphone-assisted minimally invasive neurosurgery." According to these authors, the instrument was straightforward, practical, economical, and excellent teaching aid for neurosurgeons with less training.